1-109715232-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_000851.4(GSTM5):c.559C>T(p.Arg187Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0069 in 1,614,192 control chromosomes in the GnomAD database, including 63 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0055 ( 9 hom., cov: 33)
Exomes 𝑓: 0.0070 ( 54 hom. )
Consequence
GSTM5
NM_000851.4 missense
NM_000851.4 missense
Scores
3
6
10
Clinical Significance
Conservation
PhyloP100: 2.95
Genes affected
GSTM5 (HGNC:4637): (glutathione S-transferase mu 5) Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.011373311).
BP6
Variant 1-109715232-C-T is Benign according to our data. Variant chr1-109715232-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 708302.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GSTM5 | NM_000851.4 | c.559C>T | p.Arg187Cys | missense_variant | 7/8 | ENST00000256593.8 | NP_000842.2 | |
GSTM5 | XM_005270784.5 | c.559C>T | p.Arg187Cys | missense_variant | 8/9 | XP_005270841.1 | ||
GSTM5 | XM_005270785.5 | c.247C>T | p.Arg83Cys | missense_variant | 4/5 | XP_005270842.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSTM5 | ENST00000256593.8 | c.559C>T | p.Arg187Cys | missense_variant | 7/8 | 1 | NM_000851.4 | ENSP00000256593.3 |
Frequencies
GnomAD3 genomes AF: 0.00548 AC: 834AN: 152186Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
834
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00560 AC: 1409AN: 251496Hom.: 10 AF XY: 0.00566 AC XY: 769AN XY: 135922
GnomAD3 exomes
AF:
AC:
1409
AN:
251496
Hom.:
AF XY:
AC XY:
769
AN XY:
135922
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00705 AC: 10301AN: 1461888Hom.: 54 Cov.: 32 AF XY: 0.00686 AC XY: 4992AN XY: 727244
GnomAD4 exome
AF:
AC:
10301
AN:
1461888
Hom.:
Cov.:
32
AF XY:
AC XY:
4992
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00548 AC: 834AN: 152304Hom.: 9 Cov.: 33 AF XY: 0.00491 AC XY: 366AN XY: 74474
GnomAD4 genome
AF:
AC:
834
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
366
AN XY:
74474
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
26
ALSPAC
AF:
AC:
32
ESP6500AA
AF:
AC:
5
ESP6500EA
AF:
AC:
84
ExAC
AF:
AC:
671
Asia WGS
AF:
AC:
8
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2022 | GSTM5: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 02, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;H;.
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;D;D
REVEL
Benign
Sift
Benign
.;D;D
Sift4G
Uncertain
.;D;D
Polyphen
0.73
.;P;.
Vest4
0.76, 0.58
MVP
0.29
MPC
0.47
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at